Background: Papillary glioneuronal tumors (PGNTs) are rare World Health Organization grade I neoplasms that are characterized by a benign course and excellent response to surgical resection. A few reports exist of tumors with more aggressive clinical and histologic features. In this report we detail the case of an unusually aggressive PGNT in a 67-year-old woman.
Case Description: The patient had a 3-year history of seizures and was diagnosed with a frontoparietal mass on imaging. She underwent subtotal resection with a histologic diagnosis of PGNT. Less than a year after surgery, the patient experienced recurrence of disease and underwent reresection and adjuvant radiation treatment. The patient's disease continued to progress despite radiation treatment, so adjuvant temozolomide was initiated. Molecular testing was performed and revealed a TERT promotor mutation, an FGFR3-TACC3 oncogenic fusion, and a copy number loss in CDKN2A/CDKN2B.
Conclusions: PGNTs, while typically benign, can rarely recur after surgery. Molecular testing should be performed on all PGNTs to help possibly identify more aggressive tumors and potentially reveal novel treatment options.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.wneu.2019.04.266 | DOI Listing |
Neurosurg Rev
September 2024
Department of Cariology, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha Dental College and Hospitals, Saveetha University, Chennai, 600 077, India.
Neurosurg Rev
September 2024
Jinnah Postgraduate Medical Centre, Rafiqi H J Shaheed Road, Karachi, 75510, Pakistan.
Childs Nerv Syst
December 2024
Department of Neurosurgery, Queensland Children's Hospital, 501 Stanley St, South Brisbane, QLD, 4101, Australia.
Brain arteriovenous malformations (AVM) rarely occur with spatial and/or temporal co-localisation to intracranial neoplasms. Most prior reports describe this association with high-grade gliomas; however, reports of a co-occurrence with low grade gliomas are very rare. It is unclear whether such cases represent a true co-occurrence of separate pathologies or simply an unusually vascular phenotype of the neoplasm.
View Article and Find Full Text PDFPapillary glioneuronal tumors (PGNTs), classified as Grade I by the WHO in 2016, present diagnostic challenges due to their rarity and potential for malignancy. Xiaodan Du et al.'s recent study of 36 confirmed PGNT cases provides critical insights into their imaging characteristics, revealing frequent presentation with headaches, seizures, and mass effect symptoms, predominantly located in the supratentorial region near the lateral ventricles.
View Article and Find Full Text PDFChilds Nerv Syst
October 2024
Department of Neurosurgery, The Royal Children's Hospital, Melbourne, Australia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!